X4 Pharmaceuticals
XFOR
XFOR
40 hedge funds and large institutions have $14.9M invested in X4 Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.04% less ownership
Funds ownership: 0.4% → 0.36% (-0.04%)
67% less capital invested
Capital invested by funds: $45.5M → $14.9M (-$30.6M)
Holders
40
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$204K | |
| 2 | +$197K | |
| 3 | +$99.3K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$81K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$75.4K |
Top Sellers
| 1 | -$9.83M | |
| 2 | -$113K | |
| 3 | -$20.3K | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.5K |